Literature DB >> 23192038

Crystallization and preliminary X-ray characterization of Epstein-Barr virus BHRF1 in complex with a benzoylurea peptidomimetic.

Sofia Caria1, Srishti Chugh, Duong Nhu, Guillaume Lessene, Marc Kvansakul.   

Abstract

BHRF1 is a pro-survival Bcl-2 homologue encoded by Epstein-Barr virus (EBV) that plays a key role in preventing premature host cell death during viral infection and may contribute to the development of malignancies associated with chronic EBV infections. The anti-apoptotic action of BHRF1 is based on its ability to sequester pro-apoptotic Bcl-2 family proteins, in particular Bim and Bak. These interactions have been previously studied in three dimensions by determining crystal structures of BHRF1 in complex with both Bim and Bak BH3 domains. Screening of a library of peptidomimetic compounds based on the benzoylurea scaffold that mimics critical Bim BH3 domain side chains against BHRF1 led to the identification of an inhibitor of BHRF1 that displays micromolar affinity. Single crystals were obtained from the co-crystallization of recombinant BHRF1 protein with this peptidomimetic compound. The crystals belonged to the orthorhombic space group P2(1)2(1)2(1), with unit-cell parameters a=66.8, b=91.1, c=151.9 Å. Diffraction data were collected to 2.11 Å resolution on the MX2 beamline at the Australian Synchrotron.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23192038      PMCID: PMC3509979          DOI: 10.1107/S1744309112043333

Source DB:  PubMed          Journal:  Acta Crystallogr Sect F Struct Biol Cryst Commun        ISSN: 1744-3091


  24 in total

1.  BH3 domains of BH3-only proteins differentially regulate Bax-mediated mitochondrial membrane permeabilization both directly and indirectly.

Authors:  Tomomi Kuwana; Lisa Bouchier-Hayes; Jerry E Chipuk; Christine Bonzon; Barbara A Sullivan; Douglas R Green; Donald D Newmeyer
Journal:  Mol Cell       Date:  2005-02-18       Impact factor: 17.970

2.  Differential targeting of prosurvival Bcl-2 proteins by their BH3-only ligands allows complementary apoptotic function.

Authors:  Lin Chen; Simon N Willis; Andrew Wei; Brian J Smith; Jamie I Fletcher; Mark G Hinds; Peter M Colman; Catherine L Day; Jerry M Adams; David C S Huang
Journal:  Mol Cell       Date:  2005-02-04       Impact factor: 17.970

3.  A structural viral mimic of prosurvival Bcl-2: a pivotal role for sequestering proapoptotic Bax and Bak.

Authors:  Marc Kvansakul; Mark F van Delft; Erinna F Lee; Jacqueline M Gulbis; W Douglas Fairlie; David C S Huang; Peter M Colman
Journal:  Mol Cell       Date:  2007-03-23       Impact factor: 17.970

4.  Structure of M11L: A myxoma virus structural homolog of the apoptosis inhibitor, Bcl-2.

Authors:  Andrew E Douglas; Kevin D Corbett; James M Berger; Grant McFadden; Tracy M Handel
Journal:  Protein Sci       Date:  2007-04       Impact factor: 6.725

Review 5.  BCL-2 family antagonists for cancer therapy.

Authors:  Guillaume Lessene; Peter E Czabotar; Peter M Colman
Journal:  Nat Rev Drug Discov       Date:  2008-12       Impact factor: 84.694

6.  Proapoptotic Bak is sequestered by Mcl-1 and Bcl-xL, but not Bcl-2, until displaced by BH3-only proteins.

Authors:  Simon N Willis; Lin Chen; Grant Dewson; Andrew Wei; Edwina Naik; Jamie I Fletcher; Jerry M Adams; David C S Huang
Journal:  Genes Dev       Date:  2005-05-18       Impact factor: 11.361

7.  Design, synthesis, and activity evaluation of broad-spectrum small-molecule inhibitors of anti-apoptotic Bcl-2 family proteins: characteristics of broad-spectrum protein binding and its effects on anti-tumor activity.

Authors:  Can-Hui Zheng; Hui Yang; Meng Zhang; Shi-Hai Lu; Duo Shi; Juan Wang; Xiu-Hua Chen; Xiao-Hui Ren; Jia Liu; Jia-Guo Lv; Ju Zhu; You-Jun Zhou
Journal:  Bioorg Med Chem Lett       Date:  2011-12-01       Impact factor: 2.823

8.  Vaccinia virus anti-apoptotic F1L is a novel Bcl-2-like domain-swapped dimer that binds a highly selective subset of BH3-containing death ligands.

Authors:  M Kvansakul; H Yang; W D Fairlie; P E Czabotar; S F Fischer; M A Perugini; D C S Huang; P M Colman
Journal:  Cell Death Differ       Date:  2008-06-13       Impact factor: 15.828

9.  Structural basis for apoptosis inhibition by Epstein-Barr virus BHRF1.

Authors:  Marc Kvansakul; Andrew H Wei; Jamie I Fletcher; Simon N Willis; Lin Chen; Andrew W Roberts; David C S Huang; Peter M Colman
Journal:  PLoS Pathog       Date:  2010-12-23       Impact factor: 6.823

Review 10.  Viral control of mitochondrial apoptosis.

Authors:  Lorenzo Galluzzi; Catherine Brenner; Eugenia Morselli; Zahia Touat; Guido Kroemer
Journal:  PLoS Pathog       Date:  2008-05-30       Impact factor: 6.823

View more
  2 in total

Review 1.  The Bcl-2 Family in Host-Virus Interactions.

Authors:  Marc Kvansakul; Sofia Caria; Mark G Hinds
Journal:  Viruses       Date:  2017-10-06       Impact factor: 5.048

2.  A computationally designed inhibitor of an Epstein-Barr viral Bcl-2 protein induces apoptosis in infected cells.

Authors:  Erik Procko; Geoffrey Y Berguig; Betty W Shen; Yifan Song; Shani Frayo; Anthony J Convertine; Daciana Margineantu; Garrett Booth; Bruno E Correia; Yuanhua Cheng; William R Schief; David M Hockenbery; Oliver W Press; Barry L Stoddard; Patrick S Stayton; David Baker
Journal:  Cell       Date:  2014-06-19       Impact factor: 41.582

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.